Elizabeth Wong

3.7k total citations
44 papers, 1.7k citations indexed

About

Elizabeth Wong is a scholar working on Pharmacology, Immunology and Molecular Biology. According to data from OpenAlex, Elizabeth Wong has authored 44 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmacology, 11 papers in Immunology and 10 papers in Molecular Biology. Recurrent topics in Elizabeth Wong's work include Inflammatory mediators and NSAID effects (18 papers), Estrogen and related hormone effects (10 papers) and Asthma and respiratory diseases (10 papers). Elizabeth Wong is often cited by papers focused on Inflammatory mediators and NSAID effects (18 papers), Estrogen and related hormone effects (10 papers) and Asthma and respiratory diseases (10 papers). Elizabeth Wong collaborates with scholars based in Canada, United States and Thailand. Elizabeth Wong's co-authors include Denis Riendeau, Joseph A. Mancini, S. Charleson, Wanda Cromlish, Philip J. Vickers, Jocelyne Guay, Mark Abramovitz, Martha E. Cox, Malcolm W. Greaves and Zhaoyin Wang and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Elizabeth Wong

41 papers receiving 1.6k citations

Peers

Countries citing papers authored by Elizabeth Wong

Since Specialization

Citations

This map shows the geographic impact of Elizabeth Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Wong more than expected).

Fields of papers citing papers by Elizabeth Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Wong. The network helps show where Elizabeth Wong may publish in the future.

Co-authorship network of co-authors of Elizabeth Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Wong. A scholar is included among the top collaborators of Elizabeth Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Wong. Elizabeth Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Protein‐Like Polymers Targeting Keap1/Nrf2 as Therapeutics for Myocardial Infarction 2025 ·Advanced Materials ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Michael Nguyen, (unknown), (unknown), Elizabeth Wong, (unknown), (unknown), Emily Gardner, Matthew P. Thompson, Colin Luo, Xiaoyu Zhang, Karen L. Christman, Nathan C. Gianneschi	1
2	Regional and cell specific bioactivity of injectable extracellular matrix biomaterials in myocardial infarction 2025 ·Nature Communications ·(unknown), Van K. Ninh, (unknown), Michael Nguyen, (unknown), Raymond Wang, Elizabeth Wong, Maria Karkanitsa, (unknown), Justin Yu, (unknown), (unknown), (unknown), David Calcagno, (unknown), Rebecca L. Braden, Zhenxing Fu, Kevin R. King, Karen L. Christman	0
3	Impact of COVID-19 on School Populations and Associated Factors: A Systematic Review 2022 ·International Journal of Environmental Research and Public Health ·(unknown), (unknown), Arina Anis Azlan, Hyung Joon Kim, Elizabeth Wong, Emma Mohamad	24
4	Monocyte phenotypes in systemic juvenile idiopathic arthritis (44.13) 2011 ·The Journal of Immunology ·Claudia Macaubas, Khoa D. Nguyen, Ariana Peck, Elizabeth Wong, Julia C. Buckingham, (unknown), Chetan Deshpande, Heather Alexander, Sheng-Yung Chang, Yue Sun, Jane Park, Tzielan Lee, Ann B. Begovich, Elizabeth Mellins	1
5	Pharmacological Characterization of MK-7246, a Potent and Selective CRTH2 (Chemoattractant Receptor-Homologous Molecule Expressed on T-Helper Type 2 Cells) Antagonist 2010 ·Molecular Pharmacology ·François G. Gervais, Nicole Sawyer, Rino Stocco, Martine Hamel, Connie M. Krawczyk, Susan Sillaots, Danielle Denis, Elizabeth Wong, Zhaoyin Wang, Michel Gallant, William M. Abraham, Deborah Slipetz, Michael A. Crackower, Gary P. O’Neill	46
6	Gob-5 Is Not Essential for Mucus Overproduction in Preclinical Murine Models of Allergic Asthma 2005 ·American Journal of Respiratory Cell and Molecular Biology ·Annette Robichaud, Stephanie A. Tuck, Stacia Kargman, John Tam, Elizabeth Wong, Mark Abramovitz, James R. Mortimer, Helen E. Burston, P. Masson, Jeremy A. Hirota, Deborah Slipetz, Brian P. Kennedy, Gary P. O’Neill, Steven Xanthoudakis	43
7	Pyridazinones as selective cyclooxygenase-2 inhibitors 2003 ·Bioorganic & Medicinal Chemistry Letters ·Chun Sing Li, Christine Brideau, Chi Chung Chan, Chantal Savoie, David Claveau, S. Charleson, Robert J. Gordon, Gillian Greig, Jacques Yves Gauthier, Cheuk K. Lau, Denis Riendeau, Michel Thérien, Elizabeth Wong, Petpiboon Prasit	67
8	Effects of COX-2 inhibitors on aortic prostacyclin production in cholesterol-fed rabbits 2001 ·Atherosclerosis ·Elizabeth Wong, Jingqi Huang, Philip Tagari, Denis Riendeau	36
9	PERFORMANCE COMPARISON OF TWO BIOFILTERS FOR LIFT STATION ODOR CONTROL, LEE COUNTY, FLORIDA 2000 ·Proceedings of the Water Environment Federation ·(unknown), (unknown), (unknown), (unknown), Yonghua Yang, Elizabeth Wong	0
10	Substituted heterocyclic analogs as selective COX-2 inhibitors in the flosulide class 1999 ·Bioorganic & Medicinal Chemistry Letters ·Nathalie Ouimet, Chi-Chung Chan, S. Charleson, David Claveau, Robert J. Gordon, Daniel Guay, (unknown), Marc Ouellet, D. Percival, Denis Riendeau, Elizabeth Wong, Robert Zamboni, Petpiboon Prasit	20
11	A new structural variation on the methanesulfonylphenyl class of selective cyclooxygenase-2 inhibitors 1999 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), W. Cameron Black, Christine Brideau, (unknown), S. Charleson, Wanda Cromlish, David Claveau, (unknown), Robert J. Gordon, Gillian Greig, Erich L. Grimm, Jocelyne Guay, Cheuk K. Lau, Denis Riendeau, Michel Thérien, Denise M. Visco, Elizabeth Wong, Lijing Xu, Petpiboon Prasit	23
12	Mass spectrometric analysis of arachidonyl-containing phospholipids in human U937 cells 1999 ·Journal of Mass Spectrometry ·Chun Li, Andrew McClory, Elizabeth Wong, James A. Yergey	5
13	Conversion of Prostaglandin G/H Synthase-1 into an Enzyme Sensitive to PGHS-2-selective Inhibitors by a Double His513→ Arg and Ile523→ Val Mutation 1997 ·Journal of Biological Chemistry ·Elizabeth Wong, Christopher I. Bayly, (unknown), Denis Riendeau, Joseph A. Mancini	100
14	The Effect of 5-Lipoxygenase-Activating Protein (Flap) on Substrate Utilization by 5-Lipoxygenase 1997 ·Advances in experimental medicine and biology ·Philip J. Vickers, Carmela DeLuca, Elizabeth Wong, Mark Abramovitz	2
15	Characterization of autocrine inducible prostaglandin H synthase-2 (PGHS-2) in human osteosarcoma cells 1997 ·Inflammation Research ·Elizabeth Wong, Carmela DeLuca, (unknown), S. Charleson, Wanda Cromlish, D. Denis, Stacia Kargman, Brian P. Kennedy, Marc Ouellet, Kathryn Skorey, Gary P. O’Neill, Philip J. Vickers, Denis Riendeau	34
16	Mechanism of selective inhibition of human prostaglandin G/H synthase-1 and -2 in intact cells 1996 ·Biochemical Pharmacology ·Stacia Kargman, Elizabeth Wong, Gillian Greig, Jean‐Pierre Falgueyret, Wanda Cromlish, Diane Ethier, (unknown), Denis Riendeau, Jilly F. Evans, Brian P. Kennedy, Philip Tagari, (unknown), Gary P. O’Neill	84
17	5‐lipoxygenase‐activating protein is an arachidonate binding protein 1993 ·FEBS Letters ·Joseph A. Mancini, Mark Abramovitz, Martha E. Cox, Elizabeth Wong, S. Charleson, Hélène Perrier, Zhaoyin Wang, (unknown), Philip J. Vickers	179
18	5‐Lipoxygenase‐activating protein stimulates the utilization of arachidonic acid by 5‐lipoxygenase 1993 ·European Journal of Biochemistry ·Mark Abramovitz, Elizabeth Wong, Martha E. Cox, Christopher D. Richardson, Chun Li, Philip J. Vickers	173
19	The presence of autoantibody to recombinant lipocortin-I in patients with psoriasis and psoriatic arthritis 1990 ·British Journal of Dermatology ·Jason K. Rivers, (unknown), Nicolas J. Goulding, Elizabeth Wong, John A. McGrath, R J Flower, M.W. Greaves	8
20	Lipoxygenase products of arachidonic acid in human inflamed skin. 1985 ·British Journal of Clinical Pharmacology ·AK Black, RM Barr, Elizabeth Wong, Susan D. Brain, M.W. Greaves, (unknown), Braham Shroot, CN Hensby	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact